Gregory Renza

Stock Analyst at RBC Capital

(3.42)
# 976
Out of 5,043 analysts
221
Total ratings
40.31%
Success rate
6.64%
Average return

Stocks Rated by Gregory Renza

Cidara Therapeutics
May 23, 2025
Maintains: Outperform
Price Target: $31$35
Current: $99.98
Upside: -64.99%
ACADIA Pharmaceuticals
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $22.99
Upside: +13.09%
ADC Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.29
Upside: +86.48%
Inovio Pharmaceuticals
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $2.49
Upside: +100.80%
Exelixis
May 14, 2025
Reiterates: Outperform
Price Target: $40
Current: $39.99
Upside: +0.03%
BeOne Medicines AG
May 8, 2025
Maintains: Outperform
Price Target: $312$311
Current: $315.43
Upside: -1.40%
Jazz Pharmaceuticals
May 7, 2025
Maintains: Outperform
Price Target: $182$172
Current: $139.33
Upside: +23.45%
Bicycle Therapeutics
May 2, 2025
Maintains: Outperform
Price Target: $35$32
Current: $8.12
Upside: +294.09%
Amgen
May 2, 2025
Maintains: Outperform
Price Target: $324$320
Current: $291.16
Upside: +9.91%
CG Oncology
Apr 29, 2025
Maintains: Outperform
Price Target: $66$68
Current: $44.29
Upside: +53.53%
Maintains: Sector Perform
Price Target: $113$38
Current: $123.02
Upside: -69.52%
Maintains: Outperform
Price Target: $16$15
Current: $3.10
Upside: +383.87%
Reiterates: Outperform
Price Target: $12
Current: $11.05
Upside: +8.60%
Maintains: Outperform
Price Target: $16$14
Current: $8.72
Upside: +60.55%
Maintains: Outperform
Price Target: $34$32
Current: $14.27
Upside: +124.25%
Maintains: Outperform
Price Target: $26$27
Current: $11.98
Upside: +125.38%
Reiterates: Outperform
Price Target: $61
Current: $32.37
Upside: +88.45%
Reiterates: Sector Perform
Price Target: $18
Current: $21.33
Upside: -15.61%
Maintains: Outperform
Price Target: $68$48
Current: $2.33
Upside: +1,960.09%
Reiterates: Outperform
Price Target: $6$10
Current: $5.04
Upside: +98.41%
Upgrades: Outperform
Price Target: $7$10
Current: $5.42
Upside: +84.50%
Maintains: Outperform
Price Target: $44$47
Current: $22.54
Upside: +108.52%
Maintains: Outperform
Price Target: $55$57
Current: $43.08
Upside: +32.31%
Reiterates: Sector Perform
Price Target: $4
Current: $9.65
Upside: -58.55%
Downgrades: Sector Perform
Price Target: $110$20
Current: $3.76
Upside: +431.91%
Reiterates: Outperform
Price Target: $16
Current: $0.97
Upside: +1,544.06%
Downgrades: Sector Perform
Price Target: $2,160$180
Current: $17.99
Upside: +900.56%
Maintains: Sector Perform
Price Target: $100$80
Current: $1.34
Upside: +5,870.15%
Downgrades: Sector Perform
Price Target: $105$30
Current: $0.68
Upside: +4,328.04%